 |
 |
|
|
|
| Oxaliplatin |
 |
| Oxaliplatin |
 |
| 61825-94-3 |
 |
| Used to treat patients with metastatic colorectal cancer which failed to respond to fluorouracil treatment. It has satisfying curative effect when used separately or with fluorouracil. |
 |
China SFDA Standard/EP
GMP |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
